Cargando…
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment
SIMPLE SUMMARY: The design of specific targeting reagents/drugs still remains a major goal in cancer treatment, with the aim of directing therapeutic agents into cancer cells, while avoiding damage to normal tissues and without evoking an immune response. One way to deal with this problem is to use...
Autores principales: | Hauser, Noa, Hirbawi, Joud, Saban Golub, Meshi, Zabit, Samar, Lichtenstein, Michal, Lorberboum-Galski, Haya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818074/ https://www.ncbi.nlm.nih.gov/pubmed/36612252 http://dx.doi.org/10.3390/cancers15010256 |
Ejemplares similares
-
TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human Diseases
por: Lichtenstein, Michal, et al.
Publicado: (2021) -
Evaluating Medicinal Plants for Anticancer Activity
por: Solowey, Elisha, et al.
Publicado: (2014) -
Combining flagellin and human β-defensin-3 to combat bacterial infections
por: Sabag, Ofra, et al.
Publicado: (2014) -
The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver–Serum–Brain Response
por: Sweetat, Sahar, et al.
Publicado: (2023) -
Poxvirus Exploitation of the Ubiquitin-Proteasome System
por: Barry, Michele, et al.
Publicado: (2010)